# OnCo record cediranib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cediranib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cediranib" ;
  schema:name "Cediranib"@en ;
  schema:alternateName "AZD2171"@en, "Recentin"@en ;
  schema:description "Cediranib is a tablet that blocks the blood-vessel growth signal VEGF. In alveolar soft part sarcoma, a rare very vascular sarcoma that ignores chemotherapy, a randomised trial showed it shrinks tumours and delays progression, although it was never licensed."@en ;
  schema:url <https://onco.cc/drugs/cediranib/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cediranib> ;
  schema:citation <https://en.wikipedia.org/wiki/Cediranib> ;
  onco:status "phase-2" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral VEGFR 1-3 tyrosine kinase inhibitor" ;
  onco:related <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/pazopanib/>, <https://onco.cc/drugs/anlotinib/>, <https://onco.cc/drugs/atezolizumab/> ;
  onco:cancers <https://onco.cc/cancers/alveolar-soft-part-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .